# Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer

> **NCT02075060** · PHASE2 · UNKNOWN · sponsor: **Poitiers University Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Non Muscle-invasive Bladder Cancer

## Interventions

- **PROCEDURE:** IPOI (pre-operative)
- **PROCEDURE:** IPOP (post-operative)

## Key facts

- **NCT ID:** NCT02075060
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2018-01-18
- **Final completion:** 2018-01-18
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2017-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02075060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02075060, "Evaluation of Immediate Preoperative Instillation (IPOI) of Mitomycin C Compared to Early Postoperative Instillation (IPOP) in Non-muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02075060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
